Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-15
2006-08-15
O'Hara, Eileen B. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C604S500000, C530S350000, C424S178100, C424S185100
Reexamination Certificate
active
07091181
ABSTRACT:
A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral/dental procedures. The solution preferably includes at least one tumor necrosis factor (TNF) soluble receptor at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied locally and perioperatively to a surgical site during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents.
REFERENCES:
patent: 4490379 (1984-12-01), Podos et al.
patent: 4504493 (1985-03-01), Marshall et al.
patent: 4525359 (1985-06-01), Greenway, III et al.
patent: 4640912 (1987-02-01), Hausman
patent: 4659714 (1987-04-01), Watt-Smith
patent: 4872865 (1989-10-01), Bloebaum et al.
patent: 4880791 (1989-11-01), Weithmann et al.
patent: 4938970 (1990-07-01), Hustead et al.
patent: 4971955 (1990-11-01), Soll et al.
patent: 5051443 (1991-09-01), Neufeld et al.
patent: 5124392 (1992-06-01), Robertson et al.
patent: 5145676 (1992-09-01), Fahey et al.
patent: 5180812 (1993-01-01), Dower et al.
patent: 5212196 (1993-05-01), House et al.
patent: 5272139 (1993-12-01), Cary
patent: 5288725 (1994-02-01), Witherup et al.
patent: 5304724 (1994-04-01), Newton
patent: 5319071 (1994-06-01), Dower et al.
patent: 5350761 (1994-09-01), Van Duzer et al.
patent: 5373022 (1994-12-01), Fawzi et al.
patent: 5411743 (1995-05-01), Moore et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5449756 (1995-09-01), Taniguchi et al.
patent: 5468505 (1995-11-01), Hubbell et al.
patent: 5480901 (1996-01-01), Baker et al.
patent: 5502080 (1996-03-01), Hitzig
patent: 5512055 (1996-04-01), Domb et al.
patent: 5525625 (1996-06-01), Bridges et al.
patent: 5536241 (1996-07-01), Zapol
patent: 5578707 (1996-11-01), Norick et al.
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5610184 (1997-03-01), Shahinian, Jr.
patent: 5616688 (1997-04-01), Cerami et al.
patent: 5618563 (1997-04-01), Berde et al.
patent: 5658955 (1997-08-01), Hitzig
patent: 5726148 (1998-03-01), Katoh et al.
patent: 5744482 (1998-04-01), Cohen et al.
patent: 5747532 (1998-05-01), Lai
patent: 5766585 (1998-06-01), Evans et al.
patent: 5767064 (1998-06-01), Sims et al.
patent: 5767065 (1998-06-01), Mosley et al.
patent: 5800385 (1998-09-01), Demopulos et al.
patent: 5817306 (1998-10-01), Haskill et al.
patent: 5820583 (1998-10-01), Demopulos et al.
patent: 5858017 (1999-01-01), Demopulos et al.
patent: 5860950 (1999-01-01), Demopulos et al.
patent: 5942241 (1999-08-01), Chasin et al.
patent: 5945397 (1999-08-01), Smith et al.
patent: 5972880 (1999-10-01), Pelletier et al.
patent: 6056715 (2000-05-01), Demopulos et al.
patent: 6159464 (2000-12-01), Glorioso et al.
patent: 6210394 (2001-04-01), Demopulos et al.
patent: 6242447 (2001-06-01), Demopulos et al.
patent: 6254585 (2001-07-01), Demopulos et al.
patent: 6261279 (2001-07-01), Demopulos et al.
patent: 6306820 (2001-10-01), Bendele et al.
patent: 2003/0176332 (2003-09-01), Olmarker
patent: 2040 510 (1972-02-01), None
patent: 0 160 191 (1985-11-01), None
patent: 0 166 937 (1986-01-01), None
patent: 0351755 (1990-01-01), None
patent: 0364266 (1990-04-01), None
patent: 0 424 059 (1991-04-01), None
patent: 0 538 469 (1993-04-01), None
patent: 0 623 674 (1994-11-01), None
patent: 0623674 AA1 (1994-11-01), None
patent: 0715855 (1996-06-01), None
patent: WO 96/29074 (1996-09-01), None
patent: 0710479 (1999-01-01), None
patent: WO 91/04058 (1991-04-01), None
patent: WO 92/04008 (1992-03-01), None
patent: WO 92/14453 (1992-09-01), None
patent: WO 94/06476 (1994-03-01), None
patent: WO 94/23039 (1994-10-01), None
patent: WO 95/10280 (1995-04-01), None
patent: WO 95/16435 (1995-06-01), None
patent: WO 95/16449 (1995-06-01), None
patent: WO 95/25795 (1995-09-01), None
patent: WO 95/27482 (1995-10-01), None
patent: WO 96/17869 (1996-06-01), None
patent: WO 96/26738 (1996-09-01), None
patent: WO 96/34599 (1996-11-01), None
patent: WO 96/34955 (1996-11-01), None
patent: WO 97/21445 (1997-06-01), None
patent: WO 97/24459 (1997-07-01), None
patent: WO 97/35855 (1997-10-01), None
patent: WO 98/24477 (1998-06-01), None
patent: WO 98/27098 (1998-06-01), None
patent: WO 98/38997 (1998-09-01), None
patent: WO 99/24023 (1999-05-01), None
patent: WO 99/34792 (1999-07-01), None
patent: WO 00/36108 (2000-06-01), None
patent: WO 00/38684 (2000-07-01), None
patent: WO 00/62790 (2000-10-01), None
patent: WO 01/87328 (2001-11-01), None
Van Zee et al. (Proc. Natl. Acad. Sci. vol. 89, pp. 4845-4849, Jun. 1992).
Gyrn et al., “Intra-articular Bupivacaine Plus Adrenaline for Arthroscopic Surgery of the Knee,”Acta Anaesthsiol. Scand.36:643-646 (1992).
Massey et al., “Serum lidocane levels during arthroscopy using continuous irrigation with lidocane,”Clin. Orthop.229:182-184 (1988).
Tsai et al., “Arthroscopic surgery of the knee in local anaesthesia. An analysis of age-related pathology,”Arch. Orthop. Trauma Surg.112:136-138(1993).
Debruyne et al., “Prilocaine in arthroscopy: clinical pharmacokinetics and rational use,”Clin. Pharmacol Ther.38:549-553 (1985).
Wredmark et al., “Arthroscopy under local anaesthesia using controlled pressure- irrigation with prilocaine,”J. Bone Joint Surg. [Br.]64:583-585 (1982).
Attur et al., “Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8,”Proc. Assoc. Am. Physicians110:65-72 (1998).
Thulesius, O., et al., “Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications,”J. Cardiovasc. Pharmacol.9:728-733 (1987).
Hedner, T., et al., “Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension,”Am. J. Hypertens.1:317S-323S (1988).
Hof, R.P., et al., “Antiarrhythmic and hemodynamic effects of tropisetron in anesthetized rabbits,”J. Cardiovasc. Pharmacol.22:499-505 (1993).
Naesh, O., et al., “Platelet activation in mental stress,”Clin. Physiol.13:299-307 (1993).
Evans, R.G., et al., “Effects of 5-HT-receptor and alpha 2-androceptor ligands on the haemodynamic response to acute central hypovolemia in conscious rabbits, ”Br. J. Pharmacol.109:37-47 (1993).
Van Hemelrijck, J., et al., “Blood pressure management during aortic surgery: urapidil compared to isosorbide dinitrate,”J. Cardiothorac. Vasc. Anesth.7:273-278 (1993).
Evans, R.G., et al., “A CNS serotonergic mechanism in acute central hypovolemia in conscious rabbits?”J. Cardiovasc. Pharmacol.19:1009-1017 (1992).
Vyssoulis, G.P., et al., “Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives,”Cardiovasc. Drugs Ther.4:81-84 (1990).
Sigal, S.L., et al., “Effects of Serotonin-Receptor Blockade on Angioplasty-Induced Vasospasm in an Atherosclerotic Rabbit Model,”Arterioscler. Thrombosis11:770-783 (1991).
Kalsner, S., et al., “Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm,”Science223:1435-1437 (1984).
Willerson, J.T., et al., “Specific Platelet mediators and unstable coronary artery lesions,”Circulation80:198-205 (1989).
Saxena, P.R., et al., “Cardiovascular effects on serotonin agonists and antagonists,”J. Cardiovasc. Pharmacol.15:S17-S34 (1990).
Ashton, J.H., et al., “Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries,”Circulation73:572-578 (1986).
Douglas, W.W. “Histamine and 5-hydroxytryptamine (serotonin) and their antagonists,” In:The Pharmacological Basis of Therapeutics605-638 (1985).
Kessler, W., et al., “Excitation of cutaneous afferent nerve endings in vitro by a combination
Demopulos Gregory A.
Herz Jeffrey M.
Pierce-Palmer Pamela
Kelbon Marcia S.
O'Hara Eileen B.
Omeros Corporation
Omeros Corporation
LandOfFree
Method of inhibition of pain and inflammation during surgery... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibition of pain and inflammation during surgery..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibition of pain and inflammation during surgery... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3632713